Your browser doesn't support javascript.
loading
Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy-A Single Center Prospective Cohort Study.
Ram, Ron; Freund, Tal; Halperin, Tami; Ben-Ami, Ronen; Amit, Odelia; Bar-On, Yael; Beyar-Katz, Ofrat; Eilaty, Nili; Gold, Ronit; Kay, Sigi; Glait-Santar, Chen; Hagin, David.
Afiliación
  • Ram R; BMT Unit, Tel Aviv Sourasky Medical Center, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: ronr@tlvmc.gov.il.
  • Freund T; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky Medical Center, Israel.
  • Halperin T; Laboratory for HIV diagnosis, the AIDS Center, Tel Aviv Sourasky Medical Center, Israel.
  • Ben-Ami R; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Israel.
  • Amit O; BMT Unit, Tel Aviv Sourasky Medical Center, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Bar-On Y; BMT Unit, Tel Aviv Sourasky Medical Center, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Beyar-Katz O; BMT Unit, Tel Aviv Sourasky Medical Center, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Eilaty N; BMT Unit, Tel Aviv Sourasky Medical Center, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Gold R; BMT Unit, Tel Aviv Sourasky Medical Center, Israel.
  • Kay S; BMT Unit, Tel Aviv Sourasky Medical Center, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Glait-Santar C; BMT Unit, Tel Aviv Sourasky Medical Center, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Hagin D; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky Medical Center, Israel.
Transplant Cell Ther ; 28(5): 278.e1-278.e4, 2022 05.
Article en En | MEDLINE | ID: mdl-35182795
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transplant Cell Ther Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transplant Cell Ther Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos